Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well metformin hydrochloride works in affecting
cytokines and exosomes in patients with head and neck cancer. Metformin hydrochloride may
reduce the metabolic activity of cancer cells and of surrounding supportive tissues.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University